Eun Seok Kang Selected Research

Rosiglitazone (Avandia)

2/2016	Rosiglitazone Use and the Risk of Bladder Cancer in Patients With Type 2 Diabetes.
1/2013	Rosiglitazone attenuates casein-induced hepatic endoplasmic reticulum stress in Sprague-Dawley rats: a novel model of endoplasmic reticulum stress.
12/2012	Upregulation of hepatic LRP1 by rosiglitazone: a possible novel mechanism of the beneficial effect of thiazolidinediones on atherogenic dyslipidemia.
2/2012	The effect of rosiglitazone on LRP1 expression and amyloid β uptake in human brain microvascular endothelial cells: a possible role of a low-dose thiazolidinedione for dementia treatment.
9/2008	LPIN1 genetic variation is associated with rosiglitazone response in type 2 diabetic patients.
7/2008	Rosiglitazone improves insulin sensitivity with increased serum leptin levels in patients with type 2 diabetes mellitus.
1/2008	Rosiglitazone inhibits early stage of glucolipotoxicity-induced beta-cell apoptosis.
5/2007	Depot-specific regulation of perilipin by rosiglitazone in a diabetic animal model.
2/2007	Rosiglitazone protects human neuroblastoma SH-SY5Y cells against MPP+ induced cytotoxicity via inhibition of mitochondrial dysfunction and ROS production.
2/2007	Effects of rosiglitazone and metformin on inflammatory markers and adipokines: decrease in interleukin-18 is an independent factor for the improvement of homeostasis model assessment-beta in type 2 diabetes mellitus.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eun Seok Kang Research Topics

Disease

78	Type 2 Diabetes Mellitus (MODY) 06/2022 - 12/2004
39	Insulin Resistance 01/2022 - 02/2005
17	Body Weight (Weight, Body) 01/2022 - 05/2006
12	Non-alcoholic Fatty Liver Disease 01/2022 - 10/2011
12	Diabetes Mellitus 10/2019 - 03/2007
11	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 12/2004
11	Atherosclerosis 01/2020 - 05/2008
10	Fibrosis (Cirrhosis) 01/2022 - 10/2011
10	Obesity 01/2022 - 12/2011
8	Albuminuria 08/2020 - 01/2008
8	Diabetic Nephropathies (Diabetic Nephropathy) 01/2018 - 08/2005
6	Hyperglycemia 06/2022 - 01/2014
6	Neoplasms (Cancer) 01/2022 - 10/2012
6	Inflammation (Inflammations) 11/2020 - 10/2011
6	Hypertension (High Blood Pressure) 01/2020 - 02/2014
6	Weight Loss (Weight Reduction) 01/2019 - 01/2013
6	Dyslipidemias (Dyslipidemia) 06/2017 - 12/2012
5	Fatty Liver 01/2022 - 01/2012
5	Dementia (Dementias) 01/2022 - 02/2012
5	Hepatocellular Carcinoma (Hepatoma) 05/2019 - 01/2017
5	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2018 - 01/2011
5	Diabetes Complications 01/2018 - 09/2010
5	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2016 - 08/2005
4	Weight Gain 01/2020 - 06/2006
4	Prediabetic State (Prediabetes) 01/2020 - 01/2014
4	Hypercholesterolemia 05/2019 - 02/2014
4	Hypercalcemia (Milk Alkali Syndrome) 03/2018 - 04/2005
4	Neuroblastoma 02/2007 - 02/2006
4	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2007 - 02/2006
4	Parkinson Disease (Parkinson's Disease) 02/2007 - 02/2006
3	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 02/2012
3	Proteinuria 08/2020 - 01/2019
3	Carotid Artery Diseases 01/2020 - 02/2008
3	Coronary Disease (Coronary Heart Disease) 06/2008 - 12/2004
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 01/2018
2	Hypertrophy 11/2021 - 05/2007
2	Chronic Kidney Failure (Chronic Renal Failure) 03/2020 - 08/2016
2	Disease Progression 01/2020 - 10/2011
2	Chronic Renal Insufficiency 01/2020 - 01/2020
2	Heart Failure 01/2020 - 01/2018
2	Liver Diseases (Liver Disease) 01/2019 - 01/2017

Drug/Important Bio-Agent (IBA)

38	Glucose (Dextrose)FDA LinkGeneric 06/2022 - 02/2005
28	Insulin (Novolin)FDA Link 01/2022 - 02/2005
15	Rosiglitazone (Avandia)FDA Link 02/2016 - 05/2005
13	AdiponectinIBA 01/2017 - 05/2005
12	AlbuminsIBA 08/2020 - 12/2012
11	Metformin (Glucophage)FDA LinkGeneric 06/2022 - 02/2007
11	Pioglitazone (Actos)FDA Link 01/2022 - 03/2010
11	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 02/2014
10	LipidsIBA 01/2019 - 02/2006
9	Hypoglycemic Agents (Hypoglycemics)IBA 01/2022 - 01/2006
9	Triglycerides (Triacylglycerol)IBA 01/2022 - 05/2007
8	Dipeptidyl-Peptidase IV InhibitorsIBA 06/2022 - 06/2014
8	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2006
7	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2007
7	CreatinineIBA 11/2021 - 05/2013
6	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 06/2022 - 07/2012
5	Sodium-Glucose Transporter 2 InhibitorsIBA 06/2022 - 06/2017
5	Blood Glucose (Blood Sugar)IBA 01/2022 - 01/2008
5	CholesterolIBA 01/2020 - 10/2006
5	Pharmaceutical PreparationsIBA 11/2019 - 01/2014
5	Immunosuppressive Agents (Immunosuppressants)IBA 10/2016 - 01/2008
5	C-PeptideIBA 07/2016 - 02/2006
5	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2008 - 02/2006
4	SodiumIBA 06/2022 - 06/2017
4	Hexosaminidases (Hexosaminidase)IBA 01/2022 - 07/2016
4	glimepiride (Amarel)FDA LinkGeneric 01/2022 - 02/2007
4	AdipokinesIBA 10/2019 - 02/2007
4	Sitagliptin Phosphate (Januvia)FDA Link 01/2019 - 06/2014
4	CalciumIBA 03/2018 - 06/2007
4	2,4-thiazolidinedione (thiazolidinedione)IBA 01/2018 - 02/2012
4	Methionine (L-Methionine)FDA Link 10/2017 - 10/2011
4	Choline (Choline Chloride)IBA 10/2017 - 10/2011
4	C-Reactive ProteinIBA 03/2016 - 12/2004
4	LeptinIBA 01/2012 - 07/2008
4	NeurotoxinsIBA 02/2007 - 02/2006
3	Nonesterified Fatty Acids (NEFA)IBA 01/2022 - 05/2007
3	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2022 - 06/2014
3	Ezetimibe (Zetia)FDA Link 01/2022 - 10/2017
3	ipragliflozinIBA 11/2021 - 01/2019
3	LinagliptinIBA 01/2021 - 08/2016
3	ThiazolidinedionesIBA 02/2019 - 02/2012
3	SymportersIBA 01/2019 - 06/2017
3	HDL CholesterolIBA 05/2013 - 10/2006
3	lithospermate BIBA 09/2010 - 05/2008
3	LDL CholesterolIBA 05/2009 - 10/2006
2	Fatty Acids (Saturated Fatty Acids)IBA 11/2020 - 12/2010
2	EnzymesIBA 11/2020 - 04/2016
2	isonitrosoacetophenoneIBA 08/2020 - 01/2019
2	3- (4- (4- (3- methyl- 1- phenyl- 1H- pyrazol- 5- yl)piperazin- 1- yl)pyrrolidin- 2- ylcarbonyl)thiazolidineIBA 01/2020 - 01/2019
2	InterleukinsIBA 01/2020 - 12/2007
2	LC15-0444IBA 01/2020 - 12/2019
2	Hormones (Hormone)IBA 01/2020 - 11/2016
2	InflammasomesIBA 01/2020 - 10/2017
2	dapagliflozinIBA 01/2019 - 01/2018
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2019 - 08/2005
2	Amyloid (Amyloid Fibrils)IBA 01/2019 - 02/2012

Therapy/Procedure

18	Therapeutics 06/2022 - 10/2011
11	Glycemic Control 01/2022 - 08/2006
2	Liver Transplantation 01/2019 - 05/2014